Organogenesis Holdings Inc’s recently made public that its Director Driscoll Michael Joseph acquired Company’s shares for reported $0.13 million on Mar 04 ’25. In the deal valued at $5.08 per share,25,000 shares were bought.
Then, Driscoll Michael Joseph sold 25,000 shares, generating $127,535 in total proceeds. Upon selling the shares at $5.10, the Director now owns 166,879 shares.
Before that, Gillheeney Gary S. sold 55,615 shares. Organogenesis Holdings Inc shares valued at $186,866 were divested by the President and CEO at a price of $3.36 per share. As a result of the transaction, Gillheeney Gary S. now holds 3,044,779 shares, worth roughly $15.19 million.
Lake Street initiated its Organogenesis Holdings Inc [ORGO] rating to a Buy in a research note published on June 28, 2024; the price target was $5. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early February with a ‘”an Overweight”‘ rating. Morgan Stanley began covering ORGO with “an Equal-weight” recommendation on June 15, 2023. BTIG Research revised its rating on May 24, 2023. It rated ORGO as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ORGO
On Tuesday, Organogenesis Holdings Inc [NASDAQ:ORGO] saw its stock jump 0.40% to $4.99. Over the last five days, the stock has lost -5.85%. Organogenesis Holdings Inc shares have risen nearly 55.94% since the year began. Nevertheless, the stocks have risen 75.70% over the past one year. While a 52-week high of $6.71 was reached on 03/03/25, a 52-week low of $2.16 was recorded on 01/14/25. SMA at 50 days reached $3.91, while 200 days put it at $3.24.
Levels Of Support And Resistance For ORGO Stock
The 24-hour chart illustrates a support level at 4.84, which if violated will result in even more drops to 4.70. On the upside, there is a resistance level at 5.17. A further resistance level may holdings at 5.35. The Relative Strength Index (RSI) on the 14-day chart is 56.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.25%. Stochastics %K at 52.75% indicates the stock is a holding.
How much short interest is there in Organogenesis Holdings Inc?
A steep rise in short interest was recorded in Organogenesis Holdings Inc stocks on 2025-02-28, dropping by -0.13 million shares to a total of 8.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 8.75 million shares. There was a decline of -1.55%, which implies that there is a negative sentiment for the stock.
